Immuneering (IMRX) Goodwill & Intangibles (2021 - 2026)
Immuneering (IMRX) recorded quarterly Goodwill & Intangibles of $7.0 million in Q1 2026, little changed quarter-over-quarter from $7.0 million in Q4 2025, and little changed on a YoY basis from $7.0 million in Q1 2025.
Immuneering (IMRX) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Immuneering's Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $7.0 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles changed 0.42% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $7.0 million (changed 0.42% YoY), while the FY2025 annual figure was $7.0 million, changed 0.42% from the prior year.
- Goodwill & Intangibles was $7.0 million for Q1 2026 at Immuneering, roughly flat from $7.0 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $7.1 million in Q1 2022 to a low of $7.0 million in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $7.1 million across 5 years, with a median of $7.1 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles dropped 0.58% in 2022, then retreated 0.41% in 2023.
- A 5-year view of Goodwill & Intangibles shows it stood at $7.1 million in 2022, then retreated by 0.41% to $7.1 million in 2023, then declined by 0.41% to $7.0 million in 2024, then declined by 0.42% to $7.0 million in 2025, then fell by 0.1% to $7.0 million in 2026.
- The last three Goodwill & Intangibles figures came in at $7.0 million (Q1 2026), $7.0 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 7.01 Mn |
| Sep 30, 2025 | 7.02 Mn |
| Jun 30, 2025 | 7.03 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 7.04 Mn |
| Sep 30, 2024 | 7.05 Mn |
| Jun 30, 2024 | 7.06 Mn |
| Mar 31, 2024 | 7.06 Mn |
| Dec 31, 2023 | 7.07 Mn |
| Sep 30, 2023 | 7.08 Mn |
| Jun 30, 2023 | 7.08 Mn |
| Mar 31, 2023 | 7.09 Mn |
| Dec 31, 2022 | 7.10 Mn |
| Sep 30, 2022 | 7.11 Mn |
| Jun 30, 2022 | 7.11 Mn |
| Mar 31, 2022 | 7.12 Mn |
| Dec 31, 2021 | 7.14 Mn |